Mereo BioPharma Reaches Cooperation Agreement With Rubric Capital Management
Mereo to Appoint Four New Directors to its Board of Directors
Rubric has Withdrawn its General Meeting Requisition Notice and Related Proposals; Agrees to Standstill Provision Through Mereo's 2024 Annual